Take.Ns
TAKE.NS operates in the healthcare diagnostics industry, providing diagnostic solutions and related services to healthcare providers and patients.
Business. TAKE.NS operates in the healthcare diagnostics industry, providing diagnostic solutions and related services to healthcare providers and patients.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
TAKE.NS operates in the healthcare diagnostics industry, providing diagnostic solutions and related services to healthcare providers and patients.
TAKE.NS has a strong liquidity position, as evidenced by its current ratio of 1.48, indicating that it has sufficient current assets to cover its current liabilities. The company's cash and equivalents amount to INR 29.5 million, which provides a buffer against short-term obligations. However, the company's operating cash flow is negative at INR -164.5 million, suggesting that its core operations are not generating positive cash flow.
In terms of profitability, TAKE.NS has a return on equity (ROE) of 1.83 and a return on assets (ROA) of 1.03, which are relatively low compared to industry benchmarks. The company reported a net income of INR 374.7 million, but this was accompanied by an operating loss of INR 74.7 million, indicating that operational inefficiencies or high costs are impacting its bottom line.
The company's revenue is not disclosed, but its financials suggest a concentration in a single business line or geographic region. The absence of detailed segment or geographic revenue breakdowns in the provided data makes it difficult to assess diversification. The company's capital structure is relatively simple, with no long-term debt and a debt-to-equity ratio of 0, indicating a conservative approach to financing.
Looking at the growth trajectory, TAKE.NS has not provided specific forward-looking revenue or earnings guidance. The company's free cash flow of INR 7.44 million is modest, and with no capital expenditures reported, it appears that the company is not investing in expansion or new projects. The lack of capital expenditure may indicate a focus on maintaining current operations rather than pursuing growth opportunities.
The risk assessment for TAKE.NS indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt levels and strong equity position reduce the likelihood of financial distress. However, the negative operating cash flow is a concern and may require monitoring in the future.
Recent events and filings do not show any significant changes in the company's financial or operational status. The company's financial statements do not indicate any recent major transactions, acquisitions, or strategic shifts that would impact its future performance.
- TAKE.NS has a strong liquidity position with a current ratio of 1.48 and no long-term debt.
- The company's profitability is mixed, with a net income of INR 374.7 million but an operating loss of INR 74.7 million.
- TAKE.NS has a conservative capital structure with a debt-to-equity ratio of 0.
- The company's growth trajectory is unclear due to the lack of capital expenditures and forward-looking guidance.
- The risk assessment indicates low liquidity and dilution risks, but the negative operating cash flow is a concern.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- TAKE.NS Market data — financials · 2026-05-29